HighTide Therapeutics, Inc.

HK$3.00As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2511Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 3Y CAGR (40.10%)
Div yield —
ROE (105.14%)
Biotechnology
Beta (5Y) (0.27)
PE TTM —
TSR TTM (19.79%)
Mkt cap HK$2.010B
ROIC (27.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.87
(4.38%)
(16.55%)
Sell 6|0|4|3|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.03
0.03
0.03
0.03
9.75%
0.20%
10.43%
16.06%
Revenue¥M
222.1
218.3
218.4
216.7
9.79%
2.23%
1.11%
(5.00%)
Peers (US$256.4M)
Cap (US$)
PE
249.9M
21.32x
Capital
TTM
5Y
10Y
Leveragex
0.072
0.344
0.359
EBIT/Intx
2.583
0.181
0.181
Own earn%
(9.28)
(9.70)
(11.18)
Sh yield%
22.43
12.99
15.90
Owners
Insiders/Inst%
12.06
71.20
Short interest%
4.66
SBC / revenue%
4.95
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
6–13
$1 testx
6.8
Incr. ROIC%
8